Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 79Nasopharyngeal Carcinoma 51Uterine Cervical Neoplasms 44Lung Neoplasms 38Esophageal Neoplasms 32Head and Neck Neoplasms 28Esophageal Squamous Cell Carcinoma 28Squamous Cell Carcinoma of Head and Neck 22Stomach Neoplasms 20Breast Neoplasms 16Small Cell Lung Carcinoma 15Recurrence 12Neoplasm Metastasis 12Nasopharyngeal Neoplasms 12Carcinoma, Squamous Cell 10Ovarian Neoplasms 9Central Nervous System Neoplasms 9Neuroblastoma 8Lymphoma, Large B-Cell, Diffuse 8Pancreatic Neoplasms 7Lymphoma 7Hypopharyngeal Neoplasms 7Triple Negative Breast Neoplasms 6Oropharyngeal Neoplasms 6Neoplasms 6Biliary Tract Neoplasms 6Urinary Bladder Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Follicular 5

Interventions

Temozolomide 16Radiotherapy 7apatinib 5anlotinib 3Surgical Procedures, Operative 3Chlorotoxin 3Bevacizumab 3Aminolevulinic Acid 3Positron Emission Tomography Computed Tomography 2Pemetrexed 2Magnetic Resonance Spectroscopy 2Lomustine 2Irinotecan 2Immunotherapy, Adoptive 2Blood Specimen Collection 2vandetanib 1sodium thiosulfate 1ribociclib 1poly ICLC 1lonafarnib 1lentiviral minigene vaccine of COVID-19 coronavirus 1etoposide phosphate 1Vinblastine 1Valproic Acid 1Tranexamic Acid 1Surveys and Questionnaires 1Sunitinib 1Rivaroxaban 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Glioma × Cisplatin × Clear all
NCT01670890 2012-08-22

Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas

Peking Union Medical College Hospital

Phase 2 Unknown
120 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡